問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Linkou Chang Gung Medical Foundation
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2010-11-01 - 2016-12-31
Condition/Disease
Test Drug
Participate Sites3Sites
Terminated3Sites
2011-03-01 - 2015-12-31
Participate Sites9Sites
Terminated9Sites
2013-01-15 - 2016-12-31
chronic Hepatitis C
Danoprevir (DNV) plus ritonavir (RTV)
Participate Sites6Sites
Terminated6Sites
2012-10-01 - 2017-12-31
2012-09-01 - 2017-08-31
Participate Sites4Sites
Terminated4Sites
2013-03-01 - 2020-12-31
Participate Sites5Sites
Terminated5Sites
2014-01-01 - 2019-06-20
Non-Small Cell Lung Cancer
TECENTRIQ® (Atezolizumab)
2013-03-01 - 2022-03-30
Participate Sites2Sites
Terminated2Sites
2007-11-01 - 2011-12-31
2007-04-01 - 2011-12-31
全部
